D.E. Shaw & Co’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $198K | Buy |
51,258
+742
| +1% | +$2.87K | ﹤0.01% | 2835 |
|
|
2025
Q1 | $253K | Sell |
50,516
-409,317
| -89% | -$2.05M | ﹤0.01% | 2705 |
|
|
2024
Q4 | $3.32M | Sell |
459,833
-298,171
| -39% | -$2.15M | ﹤0.01% | 1526 |
|
|
2024
Q3 | $4.65M | Sell |
758,004
-4,358
| -0.6% | -$26.8K | ﹤0.01% | 1336 |
|
|
2024
Q2 | $5.07M | Buy |
762,362
+408,012
| +115% | +$2.71M | ﹤0.01% | 1262 |
|
|
2024
Q1 | $3.61M | Buy |
354,350
+64,624
| +22% | +$658K | ﹤0.01% | 1446 |
|
|
2023
Q4 | $3.26M | Sell |
289,726
-441,006
| -60% | -$4.96M | ﹤0.01% | 1478 |
|
|
2023
Q3 | $1.9M | Buy |
730,732
+226,494
| +45% | +$589K | ﹤0.01% | 1730 |
|
|
2023
Q2 | $1.78M | Buy |
+504,238
| New | +$1.78M | ﹤0.01% | 1799 |
|
|
2023
Q1 | – | Sell |
-27,702
| Closed | -$456K | – | 3287 |
|
|
2022
Q4 | $456K | Buy |
+27,702
| New | +$456K | ﹤0.01% | 2752 |
|
|
2022
Q3 | – | Sell |
-169,683
| Closed | -$1.99M | – | 3867 |
|
|
2022
Q2 | $1.99M | Sell |
169,683
-798,053
| -82% | -$9.34M | ﹤0.01% | 2267 |
|
|
2022
Q1 | $5.89M | Sell |
967,736
-213,501
| -18% | -$1.3M | 0.01% | 1533 |
|
|
2021
Q4 | $10.8M | Buy |
1,181,237
+225,799
| +24% | +$2.07M | 0.01% | 1082 |
|
|
2021
Q3 | $10.8M | Buy |
955,438
+127,682
| +15% | +$1.44M | 0.01% | 998 |
|
|
2021
Q2 | $8.15M | Sell |
827,756
-488,058
| -37% | -$4.81M | 0.01% | 1179 |
|
|
2021
Q1 | $18.6M | Buy |
1,315,814
+122,120
| +10% | +$1.73M | 0.02% | 732 |
|
|
2020
Q4 | $13.5M | Sell |
1,193,694
-467,136
| -28% | -$5.27M | 0.01% | 852 |
|
|
2020
Q3 | $21.9M | Buy |
+1,660,830
| New | +$21.9M | 0.02% | 577 |
|
|
2019
Q3 | – | Sell |
-12,300
| Closed | -$29K | – | 2537 |
|
|
2019
Q2 | $29K | Sell |
12,300
-800
| -6% | -$1.89K | ﹤0.01% | 2543 |
|
|
2019
Q1 | $38K | Hold |
13,100
| – | – | ﹤0.01% | 2491 |
|
|
2018
Q4 | $27K | Buy |
+13,100
| New | +$27K | ﹤0.01% | 2513 |
|